David Fairlamb

David Fairlamb has over 30 years of work experience in the field of Regulatory Affairs. David began their career in 1991 as a Regulatory Affairs Officer at Smith & Nephew Pharmaceuticals. In 1994, they moved to Smith & Nephew Healthcare as a Senior Regulatory Affairs Officer. David then worked as a European Registration Manager at Seven Seas Ltd from 1997 to 1999. From 1999 to 2004, they were a Regulatory Affairs Manager - Pharmaceuticals at Smith & Nephew Wound Management. After that, they were a Senior Vice President Medical Affairs at Renovo Ltd from 2004 to 2011. From 2011 to 2022, they were the Director & Principal Consultant at Protherax Ltd. Currently, they are a Regulatory Affairs Director at SolasCure and a Board Member at MICA Biosystems.

David Fairlamb attended the University of Wales, Cardiff from 1995 to 1997 and obtained a Postgraduate Certificate (PGC) in Regulatory Affairs. David also attended the University of Portsmouth from 1988 to 1991 and obtained a Bachelor of Science (Hons) in Pharmacology.